MicroRNA-133a mutant mice develop centronuclear myopathy (CNM)-like symptoms due to miR-133a's direct regulation of the dynamin2 (DNM2) transcript [103]. This evidence concerns the gene DNM2 and autosomal dominant centronuclear myopathy.